The current valuation score of ENDRA Life Sciences Inc is 8.87, ranking 78 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.65, which is -103.38% below the recent high of 0.02 and -67.67% above the recent low of -1.09.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.